{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T02:04:05Z","timestamp":1760234645519,"version":"build-2065373602"},"reference-count":30,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIT)","award":["2020R1A2C1010786 and 2020R1A5A2019210"],"award-info":[{"award-number":["2020R1A2C1010786 and 2020R1A5A2019210"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JPM"],"abstract":"<jats:p>Previous studies have evaluated the effects of antithrombotic agents on the performance of fecal immunochemical tests (FITs) for the detection of colorectal cancer (CRC), but the results were inconsistent and based on small sample sizes. We studied this topic using a large-scale population-based database. Using the Korean National Cancer Screening Program Database, we compared the performance of FITs for CRC detection between users and non-users of antiplatelet agents and warfarin. Non-users were matched according to age and sex. Among 5,426,469 eligible participants, 768,733 used antiplatelet agents (mono\/dual\/triple therapy, n = 701,683\/63,211\/3839), and 19,569 used warfarin, while 4,638,167 were non-users. Among antiplatelet agents, aspirin, clopidogrel, and cilostazol ranked first, second, and third, respectively, in terms of prescription rates. Users of antiplatelet agents (3.62% vs. 4.45%; relative risk (RR): 0.83; 95% confidence interval (CI): 0.78\u20130.88), aspirin (3.66% vs. 4.13%; RR: 0.90; 95% CI: 0.83\u20130.97), and clopidogrel (3.48% vs. 4.88%; RR: 0.72; 95% CI: 0.61\u20130.86) had lower positive predictive values (PPVs) for CRC detection than non-users. However, there were no significant differences in PPV between cilostazol vs. non-users and warfarin users vs. non-users. For PPV, the RR (users vs. non-users) for antiplatelet monotherapy was 0.86, while the RRs for dual and triple antiplatelet therapies (excluding cilostazol) were 0.67 and 0.22, respectively. For all antithrombotic agents, the sensitivity for CRC detection was not different between users and non-users. Use of antiplatelet agents, except cilostazol, may increase the false positives without improving the sensitivity of FITs for CRC detection.<\/jats:p>","DOI":"10.3390\/jpm11060497","type":"journal-article","created":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T15:58:44Z","timestamp":1622563124000},"page":"497","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Use of Antiplatelet Agents Decreases the Positive Predictive Value of Fecal Immunochemical Tests for Colorectal Cancer but Does Not Affect Their Sensitivity"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1963-7170","authenticated-orcid":false,"given":"Yoonsuk","family":"Jung","sequence":"first","affiliation":[{"name":"Division of Gastroenterology, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul 03181, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eui","family":"Im","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, Yonsei University College of Medicine and Cardiovascular Center, Yongin Severance Hospital, Yongin 16995, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinhee","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Ajou University School of Medicine, Suwon 16499, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyeah","family":"Lee","sequence":"additional","affiliation":[{"name":"Clinical Trial Center, Ewha Womans University Mokdong Hospital, Seoul 07985, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2550-913X","authenticated-orcid":false,"given":"Changmo","family":"Moon","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, College of Medicine, Ewha Womans University, Seoul 07985, Korea"},{"name":"Inflammation-Cancer Microenvironment Research Center, Ewha Womans University, Seoul 07804, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,6,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S1470-2045(11)70101-2","article-title":"Baseline faecal occult blood concentration as a predictor of incident colorectal neoplasia: Longitudinal follow-up of a taiwanese population-based colorectal cancer screening cohort","volume":"12","author":"Chen","year":"2011","journal-title":"Lancet Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Stegeman, I., de Wijkerslooth, T.R., Mallant-Hent, R.C., de Groot, K., Stroobants, A.K., Fockens, P., Mundt, M., Bossuyt, P.M., and Dekker, E. (2012). Implementation of population screening for colorectal cancer by repeated fecal immunochemical test (fit): Third round. BMC Gastroenterol., 12.","DOI":"10.1186\/1471-230X-12-73"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Jung, Y.S., Lee, J., and Moon, C.M. (2020). Positive fecal immunochemical test results are associated with increased risks of esophageal, stomach, and small intestine cancers. J. Clin. Med., 9.","DOI":"10.3390\/jcm9072172"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/MEG.0000000000001338","article-title":"Participation in a population-based screening for colorectal cancer using the faecal immunochemical test decreases mortality in 5 years","volume":"31","year":"2019","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1136\/gutjnl-2016-312716","article-title":"A comparative effectiveness trial of two faecal immunochemical tests for haemoglobin (fit). Assessment of test performance and adherence in a single round of a population-based screening programme for colorectal cancer","volume":"67","author":"Passamonti","year":"2018","journal-title":"Gut"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"168","DOI":"10.5217\/ir.2019.00080","article-title":"Novel biomarkers for the diagnosis and prognosis of colorectal cancer","volume":"18","author":"Oh","year":"2020","journal-title":"Intest Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/pds.3463","article-title":"Trends in the use of aspirin and nonsteroidal anti-inflammatory drugs in the general U.S. Population","volume":"23","author":"Zhou","year":"2014","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1007\/s00228-017-2296-1","article-title":"Trends in use of warfarin and direct oral anticoagulants in atrial fibrillation in norway, 2010 to 2015","volume":"73","author":"Kjerpeseth","year":"2017","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"317","DOI":"10.5217\/ir.2019.00021","article-title":"Prevalence and risk factors of colorectal cancer in asia","volume":"17","author":"Wong","year":"2019","journal-title":"Intest Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1136\/gutjnl-2018-316344","article-title":"Effect of anticoagulants and nsaids on accuracy of faecal immunochemical tests (fits) in colorectal cancer screening: A systematic review and meta-analysis","volume":"68","author":"Nieuwenburg","year":"2019","journal-title":"Gut"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1053\/j.gastro.2019.01.040","article-title":"Effects of oral anticoagulants and aspirin on performance of fecal immunochemical tests in colorectal cancer screening","volume":"156","author":"Randel","year":"2019","journal-title":"Gastroenterology"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/ajg.2009.14","article-title":"Sensitivity, but not specificity, of a quantitative immunochemical fecal occult blood test for neoplasia is slightly increased by the use of low-dose aspirin, nsaids, and anticoagulants","volume":"104","author":"Levi","year":"2009","journal-title":"Am. J. Gastroenterol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1001\/jama.2010.1773","article-title":"Low-dose aspirin use and performance of immunochemical fecal occult blood tests","volume":"304","author":"Brenner","year":"2010","journal-title":"JAMA"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/MEG.0b013e3283438aac","article-title":"Anticoagulant or aspirin treatment does not affect the positive predictive value of an immunological fecal occult blood test in patients undergoing colorectal cancer screening: Results from a nested in a cohort case-control study","volume":"23","author":"Mandelli","year":"2011","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.dld.2015.11.020","article-title":"Predictors of advanced colorectal neoplasia at initial and surveillance colonoscopy after positive screening immunochemical faecal occult blood test","volume":"48","author":"Botteri","year":"2016","journal-title":"Dig. Liver Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1177\/2050640617707094","article-title":"Effect of aspirin on the diagnostic accuracy of the faecal immunochemical test for colorectal advanced neoplasia","volume":"6","author":"Bujanda","year":"2018","journal-title":"United Eur. Gastroenterol. J."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1001\/jama.2019.4755","article-title":"Effect of a single aspirin dose prior to fecal immunochemical testing on test sensitivity for detecting advanced colorectal neoplasms: A randomized clinical trial","volume":"321","author":"Brenner","year":"2019","journal-title":"JAMA"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.dld.2016.06.011","article-title":"Prescription drugs associated with false-positive results when using faecal immunochemical tests for colorectal cancer screening","volume":"48","author":"Garcia","year":"2016","journal-title":"Dig. Liver Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.mayocp.2013.04.016","article-title":"Effect of aspirin and antiplatelet drugs on the outcome of the fecal immunochemical test","volume":"88","author":"Bujanda","year":"2013","journal-title":"Mayo Clin. Proc."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"191","DOI":"10.4143\/crt.2010.42.4.191","article-title":"Results of colorectal cancer screening of the national cancer screening program in korea, 2008","volume":"42","author":"Shim","year":"2010","journal-title":"Cancer Res. Treat."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3109\/00365521.2012.668930","article-title":"A comparison of qualitative and quantitative fecal immunochemical tests in the korean national colorectal cancer screening program","volume":"47","author":"Park","year":"2012","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Shin, A., Choi, K.S., Jun, J.K., Noh, D.K., Suh, M., Jung, K.W., Kim, B.C., Oh, J.H., and Park, E.C. (2013). Validity of fecal occult blood test in the national cancer screening program, korea. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0079292"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/ajg.2018.23","article-title":"Risk of interval cancer in fecal immunochemical test screening significantly higher during the summer months: Results from the national cancer screening program in korea","volume":"113","author":"Cha","year":"2018","journal-title":"Am. J. Gastroenterol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1093\/aje\/kwh090","article-title":"A modified poisson regression approach to prospective studies with binary data","volume":"159","author":"Zou","year":"2004","journal-title":"Am. J. Epidemiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/den.12208","article-title":"Antithrombotic drug does not affect the positive predictive value of an immunochemical fecal occult blood test","volume":"26","author":"Tsuji","year":"2014","journal-title":"Dig. Endosc."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1159\/000494251","article-title":"The effects of direct oral anticoagulants, warfarin, aspirin and thienopyridine on the performance of immunochemical, faecal, occult blood tests","volume":"100","author":"Niikura","year":"2019","journal-title":"Digestion"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.gie.2013.04.179","article-title":"Novel oral anticoagulants in gastroenterology practice","volume":"78","author":"Desai","year":"2013","journal-title":"Gastrointest. Endosc."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.lfs.2014.06.017","article-title":"Comparative effects of the anti-platelet drugs, clopidogrel, ticlopidine, and cilostazol on aspirin-induced gastric bleeding and damage in rats","volume":"110","author":"Takeuchi","year":"2014","journal-title":"Life Sci."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1159\/000360811","article-title":"Benefit of cilostazol in patients with high risk of bleeding: Subanalysis of cilostazol stroke prevention study 2","volume":"37","author":"Uchiyama","year":"2014","journal-title":"Cerebrovasc. Dis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.gie.2014.08.006","article-title":"Factors associated with false-positive and false-negative fecal immunochemical test results for colorectal cancer screening","volume":"81","author":"Wong","year":"2015","journal-title":"Gastrointest. Endosc."}],"container-title":["Journal of Personalized Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4426\/11\/6\/497\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:09:50Z","timestamp":1760162990000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4426\/11\/6\/497"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,1]]},"references-count":30,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021,6]]}},"alternative-id":["jpm11060497"],"URL":"https:\/\/doi.org\/10.3390\/jpm11060497","relation":{},"ISSN":["2075-4426"],"issn-type":[{"type":"electronic","value":"2075-4426"}],"subject":[],"published":{"date-parts":[[2021,6,1]]}}}